Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| §112 only | 1 (25%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CULLEN, SEAN P | 1 | 68.9% | +28.8% |
| NGUYEN, TRI V | 1 | 67.6% | +57.8% |
| REILLY, SOPHIA JANE | 1 | 59.3% | +51.1% |
| PETERS, ALEC JON | 1 | 68.6% | +61.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17602061 | INTRACELLULAR DELIVERY OF ANTI-KRAS ANTIBODIES FORMULATED INTO NANOCAPSULES | PETERS, ALEC JON | 112d overdue |
| 18245123 | SUPRAMOLECULAR FLUID | CULLEN, SEAN P | 11d overdue |
| 18044411 | COMPOUND FOR BATTERIES | NGUYEN, TRI V | 29d |
| 18006908 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | REILLY, SOPHIA JANE | 43d |
| Art Unit | Apps |
|---|---|
| 1725 | 1 |
| 1764 | 1 |
| 1627 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18245123 | SUPRAMOLECULAR FLUID | CULLEN, SEAN P | 1725 | §102 | Final Rejection | 11d overdue | Pending | Mar 13, 2023 |
| 18044411 | COMPOUND FOR BATTERIES | NGUYEN, TRI V | 1764 | §103 | Non-Final OA | 29d | Pending | Mar 08, 2023 |
| 18006908 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | REILLY, SOPHIA JANE | 1627 | §112 | Final Rejection | 43d | Pending | Jan 26, 2023 |
| 17602061 | INTRACELLULAR DELIVERY OF ANTI-KRAS ANTIBODIES FORMULATED INTO NANOCAPSULES | PETERS, ALEC JON | 1641 | Other | Non-Final OA | 112d overdue | Pending | Oct 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial